Finny Kuruvilla

Finny Kuruvilla serves as CIO for Eventide Funds and Portfolio Manager for the Eventide Gilead Fund and the Eventide Healthcare & Life Sciences Fund.

Dr. Kuruvilla has a unique background in healthcare, statistics, and investing. Concurrent with Eventide, from 2008 through 2016, he was a Principal at Clarus Ventures, a leading healthcare and life sciences venture capital firm. Prior to joining Eventide, from 2005-2008, Dr. Kuruvilla was a postdoctoral research scientist in medical genetics at the Broad Institute of Harvard and MIT. From 2003-2007, Dr. Kuruvilla was resident, chief resident, and clinical fellow at the Brigham and Women’s Hospital and Children’s Hospital Boston.

He holds an MD from Harvard Medical School, a PhD in Chemistry and Chemical Biology from Harvard University, a master’s degree in Electrical Engineering and Computer Science from MIT, and a bachelor’s degree from Caltech in Chemistry.